par Ilboudo, Dieudonné
;Samadoulougou, Sékou;Yombi, Jean-Cyr;Neven, Anouk;Kirakoya, Fati 
Référence Pharmacoepidemiology and drug safety, 35, 3, page (e70347)
Publication Publié, 2026-03
;Samadoulougou, Sékou;Yombi, Jean-Cyr;Neven, Anouk;Kirakoya, Fati 
Référence Pharmacoepidemiology and drug safety, 35, 3, page (e70347)
Publication Publié, 2026-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Ilboudo, Dieudonné; Samadoulougou, Sékou; Yombi, Jean-Cyr; Neven, Anouk; Kirakoya, Fati |
| Informations sur la publication: | Pharmacoepidemiology and drug safety, 35, 3, page (e70347) |
| Statut de publication: | Publié, 2026-03 |
| Sujet CREF: | Santé publique |
| Mots-clés: | Belgium |
| adherence | |
| antiretroviral therapy | |
| group‐based trajectory modeling | |
| people living with HIV | |
| MeSH keywords: | Humans |
| Male | |
| Belgium -- epidemiology | |
| Female | |
| Adult | |
| HIV Infections -- drug therapy -- epidemiology | |
| Middle Aged | |
| Retrospective Studies | |
| Anti-HIV Agents -- administration & dosage -- therapeutic use | |
| Longitudinal Studies | |
| Medication Adherence | |
| COVID-19 -- epidemiology | |
| Follow-Up Studies | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1053-8569 |
| info:doi/10.1002/pds.70347 | |
| info:pmid/41818897 |



